世界のサイトメガロウイルス（CMV）治療薬市場は、予測期間中に約5.44 %のCAGRで推移し、2022年から2026年の間に3億3,221万USドルの成長が見込まれています。本レポートは、総体的な分析、市場規模と予測、動向、成長推進要因、課題、および約25社のベンダーを対象とするベンダー分析を提供しています。
本レポートは、現在の世界市場シナリオ、最新動向と成長推進要因、および全体的な市場環境に関する最新の分析を提供します。CMVのリスク要因の増加、本疾患の再発性、先天性CMVの高い有病率などが市場を牽引しています。
本調査は、今後数年間でサイトメガロウイルス（CMV）治療薬市場の成長を促進する主な理由の1つとして、薬剤の再処方を特定しています。また、ワクチンと新生児スクリーニングの出現は、市場でかなりの需要につながるでしょう。
TechNavio社の堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されており、これに沿って、主要なサイトメガロウイルス（CMV）治療薬市場ベンダーの詳細な分析を提供します
この調査は、業界の主要な参加者からの情報を含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加えて、包括的な市場とベンダー情勢が含まれています。
TechNavio社は、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析により、複数のソースからのデータの調査、統合、および集計により、市場の詳細な状況を提示します。また、業界の主要なインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは、包括的で信頼性が高く、一次および二次の広範な調査の結果です。TechNavio社の市場調査レポートは、完全な競争環境と、質的および量的調査を使用して正確な市場成長を予測する詳細なベンダー選択の調査手法と分析を提供します。
目次
1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Route of Administration
5.1 Market segments
Exhibit 24: Chart on Route of Administration - Market share 2021-2026 (%)
Exhibit 25: Data Table on Route of Administration - Market share 2021-2026 (%)
5.2 Comparison by Route of Administration
Exhibit 26: Chart on Comparison by Route of Administration
Exhibit 27: Data Table on Comparison by Route of Administration
5.3 Oral - Market size and forecast 2021-2026
Exhibit 28: Chart on Oral - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Oral - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Oral - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Oral - Year-over-year growth 2021-2026 (%)
5.4 Parenteral - Market size and forecast 2021-2026
Exhibit 32: Chart on Parenteral - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Parenteral - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Parenteral - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Parenteral - Year-over-year growth 2021-2026 (%)
5.5 Others - Market size and forecast 2021-2026
Exhibit 36: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Others - Year-over-year growth 2021-2026 (%)
5.6 Market opportunity by Route of Administration
Exhibit 40: Market opportunity by Route of Administration ($ million)
6 Customer Landscape
6.1 Customer landscape overview
Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 44: Chart on Geographic comparison
Exhibit 45: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Denmark - Market size and forecast 2021-2026
Exhibit 66: Chart on Denmark - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on Denmark - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on Denmark - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on Denmark - Year-over-year growth 2021-2026 (%)
7.9 China - Market size and forecast 2021-2026
Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
7.10 Canada - Market size and forecast 2021-2026
Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.11 India - Market size and forecast 2021-2026
Exhibit 78: Chart on India - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on India - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on India - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on India - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 82: Market opportunity By Geographical Landscape ($ million)
8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 83: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends
9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 85: Overview on factors of disruption
9.4 Industry risks
Exhibit 86: Impact of key risks on business
10 Vendor Analysis
10.1 Vendors covered
Exhibit 87: Vendors covered
10.2 Market positioning of vendors
Exhibit 88: Matrix on vendor position and classification
10.3 AstraZeneca Plc
Exhibit 89: AstraZeneca Plc - Overview
Exhibit 90: AstraZeneca Plc - Product / Service
Exhibit 91: AstraZeneca Plc - Key news
Exhibit 92: AstraZeneca Plc - Key offerings
10.4 Bausch Health Companies Inc.
Exhibit 93: Bausch Health Companies Inc. - Overview
Exhibit 94: Bausch Health Companies Inc. - Business segments
Exhibit 95: Bausch Health Companies Inc. - Key news
Exhibit 96: Bausch Health Companies Inc. - Key offerings
Exhibit 97: Bausch Health Companies Inc. - Segment focus
10.5 Chimerix Inc.
Exhibit 98: Chimerix Inc. - Overview
Exhibit 99: Chimerix Inc. - Product / Service
Exhibit 100: Chimerix Inc. - Key offerings
10.6 Exela Pharma Sciences LLC
Exhibit 101: Exela Pharma Sciences LLC - Overview
Exhibit 102: Exela Pharma Sciences LLC - Product / Service
Exhibit 103: Exela Pharma Sciences LLC - Key offerings
10.7 F. Hoffmann La Roche Ltd.
Exhibit 104: F. Hoffmann La Roche Ltd. - Overview
Exhibit 105: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 106: F. Hoffmann La Roche Ltd. - Key news
Exhibit 107: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 108: F. Hoffmann La Roche Ltd. - Segment focus
10.8 Fortress Biotech Inc.
Exhibit 109: Fortress Biotech Inc. - Overview
Exhibit 110: Fortress Biotech Inc. - Business segments
Exhibit 111: Fortress Biotech Inc. - Key offerings
Exhibit 112: Fortress Biotech Inc. - Segment focus
10.9 Gilead Sciences Inc.
Exhibit 113: Gilead Sciences Inc. - Overview
Exhibit 114: Gilead Sciences Inc. - Product / Service
Exhibit 115: Gilead Sciences Inc. - Key news
Exhibit 116: Gilead Sciences Inc. - Key offerings
10.10 Merck and Co. Inc.
Exhibit 117: Merck and Co. Inc. - Overview
Exhibit 118: Merck and Co. Inc. - Business segments
Exhibit 119: Merck and Co. Inc. - Key news
Exhibit 120: Merck and Co. Inc. - Key offerings
Exhibit 121: Merck and Co. Inc. - Segment focus
10.11 Takeda Pharmaceutical Co. Ltd.
Exhibit 122: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 123: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibit 124: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 125: Takeda Pharmaceutical Co. Ltd. - Key offerings
10.12 Teva Pharmaceutical Industries Ltd.
Exhibit 126: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 127: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 128: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 129: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 130: Teva Pharmaceutical Industries Ltd. - Segment focus
11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 131: Inclusions checklist
Exhibit 132: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 133: Currency conversion rates for US$
11.4 Research methodology
Exhibit 134: Research methodology
Exhibit 135: Validation techniques employed for market sizing
Exhibit 136: Information sources
11.5 List of abbreviations
Exhibit 137: List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Route of Administration - Market share 2021-2026 (%)
Exhibits25: Data Table on Route of Administration - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Route of Administration
Exhibits27: Data Table on Comparison by Route of Administration
Exhibits28: Chart on Oral - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Oral - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Oral - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Oral - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Parenteral - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Parenteral - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Parenteral - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Parenteral - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits40: Market opportunity by Route of Administration ($ million)
Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits44: Chart on Geographic comparison
Exhibits45: Data Table on Geographic comparison
Exhibits46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Denmark - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Denmark - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Denmark - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Denmark - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on India - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on India - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on India - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on India - Year-over-year growth 2021-2026 (%)
Exhibits82: Market opportunity By Geographical Landscape ($ million)
Exhibits83: Impact of drivers and challenges in 2021 and 2026
Exhibits84: Overview on Criticality of inputs and Factors of differentiation
Exhibits85: Overview on factors of disruption
Exhibits86: Impact of key risks on business
Exhibits87: Vendors covered
Exhibits88: Matrix on vendor position and classification
Exhibits89: AstraZeneca Plc - Overview
Exhibits90: AstraZeneca Plc - Product / Service
Exhibits91: AstraZeneca Plc - Key news
Exhibits92: AstraZeneca Plc - Key offerings
Exhibits93: Bausch Health Companies Inc. - Overview
Exhibits94: Bausch Health Companies Inc. - Business segments
Exhibits95: Bausch Health Companies Inc. - Key news
Exhibits96: Bausch Health Companies Inc. - Key offerings
Exhibits97: Bausch Health Companies Inc. - Segment focus
Exhibits98: Chimerix Inc. - Overview
Exhibits99: Chimerix Inc. - Product / Service
Exhibits100: Chimerix Inc. - Key offerings
Exhibits101: Exela Pharma Sciences LLC - Overview
Exhibits102: Exela Pharma Sciences LLC - Product / Service
Exhibits103: Exela Pharma Sciences LLC - Key offerings
Exhibits104: F. Hoffmann La Roche Ltd. - Overview
Exhibits105: F. Hoffmann La Roche Ltd. - Business segments
Exhibits106: F. Hoffmann La Roche Ltd. - Key news
Exhibits107: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits108: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits109: Fortress Biotech Inc. - Overview
Exhibits110: Fortress Biotech Inc. - Business segments
Exhibits111: Fortress Biotech Inc. - Key offerings
Exhibits112: Fortress Biotech Inc. - Segment focus
Exhibits113: Gilead Sciences Inc. - Overview
Exhibits114: Gilead Sciences Inc. - Product / Service
Exhibits115: Gilead Sciences Inc. - Key news
Exhibits116: Gilead Sciences Inc. - Key offerings
Exhibits117: Merck and Co. Inc. - Overview
Exhibits118: Merck and Co. Inc. - Business segments
Exhibits119: Merck and Co. Inc. - Key news
Exhibits120: Merck and Co. Inc. - Key offerings
Exhibits121: Merck and Co. Inc. - Segment focus
Exhibits122: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits123: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits124: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits125: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits126: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits127: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits128: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits129: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits130: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits131: Inclusions checklist
Exhibits132: Exclusions checklist
Exhibits133: Currency conversion rates for US$
Exhibits134: Research methodology
Exhibits135: Validation techniques employed for market sizing
Exhibits136: Information sources
Exhibits137: List of abbreviations
